Metagenomic profiling of the viromes of plasma collected from blood donors with elevated serum alanine aminotransferase levels

Transfusion

Volumn 55, Issue 8, 2015, Pages 1889-1899

  Furuta, Rika A ^a   Sakamoto, Hirotaka ^a   Kuroishi, Ayumu ^a   Yasiui, Kazuta ^a   Matsukura, Harumichi ^a   Hirayama, Fumiya ^a  

^a Japanese Red Cross Kinki Block Blood Center   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; VIRUS DNA; VIRUS RNA;

ADOLESCENT; ADULT; AGED; ANELLOVIRIDAE; ARTICLE; BLOOD DONOR; BLOOD SAMPLING; CONTROLLED STUDY; ENTEROVIRUS A; ENTEROVIRUS B; EPSTEIN BARR VIRUS; FEMALE; FLAVIVIRIDAE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GENE EXPRESSION PROFILING; GENE SEQUENCE; GROUPS BY AGE; HEPATITIS G VIRUS; HERPESVIRIDAE; HUMAN; HUMAN RHINOVIRUS C; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METAGENOMICS; PICORNAVIRIDAE; REAL TIME POLYMERASE CHAIN REACTION; SEN VIRUS; SEROLOGY; SEX DIFFERENCE; TORQUE TENO VIRUS 1; TORQUE TENO VIRUS INFECTION; VIRUS GENOME; BLOOD; BLOOD SAFETY; BLOODBORNE BACTERIUM; DNA SEQUENCE; ENZYMOLOGY; EPIDEMIOLOGY; GENETICS; ISOLATION AND PURIFICATION; JAPAN; MIDDLE AGED; PLASMA; PROCEDURES; SEQUENCE ANALYSIS; VIREMIA; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ALANINE TRANSAMINASE; ANELLOVIRUS; BLOOD DONORS; BLOOD SAFETY; BLOOD-BORNE PATHOGENS; DNA, VIRAL; FEMALE; FLAVIVIRIDAE; GENOME, VIRAL; HERPESVIRIDAE; HUMANS; JAPAN; MALE; METAGENOMICS; MIDDLE AGED; PICORNAVIRIDAE; PLASMA; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; VIREMIA; YOUNG ADULT;

EID: 84938997263     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13057     Document Type: Article

References (50)

1. Prince AM, Gershon RK,. The use of serum enzyme determinations to detect anicteric hepatitis. Transfusion 1965; 5: 120-34.
2. Alter HJ, Klein HG,. The hazards of blood transfusion in historical perspective. Blood 2008; 112: 2617-26.
3. van der Poel CL, Janssen MP, Behr-Gross ME,. The collection, testing and use of blood and blood components in Europe. 2008 report. Strasbourg: European Directorate for the Quality of Medicines and HealthCare of the Council of Europe (EDQM); 2011 [cited 2014 Dec 10]. Available from: http://www.edqm.eu/site/The-Collection-Testing-and-Use-of-Blood-and-Blood-3pdf-en-0141-2.html.
4. Tanaka J, Kumagai J, Katayama K, et al., Sex- and age-specific carriers of hepatitis B and C viruses in Japan estimated by the prevalence in the 3,485,648 first-time blood donors during 1995-2000. Intervirology 2004; 47: 32-40.
5. Taira R, Satake M, Momose S, et al., Residual risk of transfusion-transmitted hepatitis B virus (HBV) infection caused by blood components derived from donors with occult HBV infection in Japan. Transfusion 2013; 53: 1393-404.
6. Satake M, Taira R, Yugi H, et al., Infectivity of blood components with low hepatitis B virus DNA levels identified in a look back program. Transfusion 2007; 47: 1197-205.
7. Takeda H, Matsubayashi K, Sakata H, et al., A nationwide survey for prevalence of hepatitis E virus antibody in qualified blood donors in Japan. Vox Sang 2010; 99: 307-13.
8. Petrova M, Kamburov V,. Epstein-Barr virus: silent companion or causative agent of chronic liver disease? World J Gastroenterol 2010; 16: 4130-4.
9. Azad AK, Ahmed T, Chowdhury AJ, et al., Cytomegalovirus induced hepatitis in an immunocompetent host. Mymensingh Med J 2008; 17: S104-6.
10. Yozwiak NL, Skewes-Cox P, Stenglein MD, et al., Virus identification in unknown tropical febrile illness cases using deep sequencing. PLoS Negl Trop Dis 2012; 6: e1485.
11. Popgeorgiev N, Colson P, Thuret I, et al., Marseillevirus prevalence in multitransfused patients suggests blood transmission. J Clin Virol 2013; 58: 722-5.
12. He B, Zhang Y, Xu L, et al., Identification of diverse Alphacoronaviruses and genomic characterization of a novel severe acute respiratory syndrome-like coronavirus from bats in China. J Virol 2014; 88: 7070-82.
13. Phan TG, Vo NP, Bonkoungou IJ, et al., Acute diarrhea in West African children: diverse enteric viruses and a novel parvovirus genus. J Virol 2012; 86: 11024-30.
14. Smits SL, Zijlstra EE, van Hellemond JJ, et al., Novel cyclovirus in human cerebrospinal fluid, Malawi, 2010-2011. Emerg Infect Dis 2013; 19.
15. Lunter G, Goodson M,. Stampy: a statistical algorithm for sensitive and fast mapping of Illumina sequence reads. Genome Res 2011; 21: 936-9.
16. Kimura H, Morita M, Yabuta Y, et al., Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999; 37: 132-6.
17. Silva SA, Rodrigues CL, Campos AF, et al., Evaluation of GBV-C/HVG viremia in HIV-infected women. Rev Inst Med Trop Sao Paulo 2012; 54: 31-5.
18. Serin MS, Koksal F, Oksuz M, et al., SEN virus prevalence among non-B and non-C hepatitis patients with high liver function tests in the south of Turkey. Jpn J Infect Dis 2005; 58: 349-52.
19. Echavarria M, Forman M, Ticehurst J, et al., PCR method for detection of adenovirus in urine of healthy and human immunodeficiency virus-infected individuals. J Clin Microbiol 1998; 36: 3323-6.
20. Jing R, Cui M, Wang H, et al., Cell-free DNA: characteristics, detection and its applications in myocardial infarction. Curr Pharm Des 2013; 19: 5135-45.
21. Stapleton JT, Foung S, Muerhoff AS, et al., The GB viruses: a review and proposed classification of GBV-A, GBV-C (HGV), and GBV-D in genus Pegivirus within the family Flaviviridae. J Gen Virol 2011; 92: 233-46.
22. International Committee on Taxonomy of Viruses. Virus taxonomy: 2012 release 2014 [cited 2014 Dec 10]. Available from: http://ictvonline.org/virusTaxonomy.asp?version=2012.
23. Allander T, Emerson SU, Engle RE, et al., A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci U S A 2001; 98: 11609-14.
24. Simons JN, Leary TP, Dawson GJ, et al., Isolation of novel virus-like sequences associated with human hepatitis. Nat Med 1995; 1: 564-9.
25. Linnen J, Wages JJ Jr, Zhang-Keck ZY, et al., Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 1996; 271: 505-8.
26. Laskus T, Radkowski M, Wang LF, et al., Lack of evidence for hepatitis G virus replication in the livers of patients coinfected with hepatitis C and G viruses. J Virol 1997; 71: 7804-6.
27. Pessoa MG, Terrault NA, Detmer J, et al., Quantitation of hepatitis G and C viruses in the liver: evidence that hepatitis G virus is not hepatotropic. Hepatology 1998; 27: 877-80.
28. Radkowski M, Wang LF, Cianciara J, et al., Analysis of hepatitis G virus/GB virus C quasispecies and replication sites in human subjects. Biochem Biophys Res Commun 1999; 258: 296-9.
29. Radkowski M, Kubicka J, Kisiel E, et al., Detection of active hepatitis C virus and hepatitis G virus/GB virus C replication in bone marrow in human subjects. Blood 2000; 95: 3986-9.
30. Reshetnyak VI, Karlovich TI, Ilchenko LU,. Hepatitis G virus. World J Gastroenterol 2008; 14: 4725-34.
31. Alter HJ, Nakatsuji Y, Melpolder J, et al., The incidence of transfusion-associated hepatitis G virus infection and its relation to liver disease. N Engl J Med 1997; 336: 747-54.
32. Nishizawa T, Okamoto H, Konishi K, et al., A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem Biophys Res Commun 1997; 241: 92-7.
33. Takahashi K, Iwasa Y, Hijikata M, et al., Identification of a new human DNA virus (TTV-like mini virus, TLMV) intermediately related to TT virus and chicken anemia virus. Arch Virol 2000; 145: 979-93.
34. Jones MS, Kapoor A, Lukashov VV, et al., New DNA viruses identified in patients with acute viral infection syndrome. J Virol 2005; 79: 8230-6.
35. Tanaka Y, Primi D, Wang RY, et al., Genomic and molecular evolutionary analysis of a newly identified infectious agent (SEN virus) and its relationship to the TT virus family. J Infect Dis 2001; 183: 359-67.
36. Kazi A, Miyata H, Kurokawa K, et al., High frequency of postnatal transmission of TT virus in infancy. Arch Virol 2000; 145: 535-40.
37. Ninomiya M, Takahashi M, Nishizawa T, et al., Development of PCR assays with nested primers specific for differential detection of three human anelloviruses and early acquisition of dual or triple infection during infancy. J Clin Microbiol 2008; 46: 507-14.
38. Nawaz-ul-Rehman MS, Fauquet CM,. Evolution of geminiviruses and their satellites. FEBS Lett 2009; 583: 1825-32.
39. Biagini P, Charrel RN, de Micco P, et al., Association of TT virus primary infection with rhinitis in a newborn. Clin Infect Dis 2003; 36: 128-9.
40. Shiramizu B, Yu Q, Hu N, et al., Investigation of TT virus in the etiology of pediatric acute lymphoblastic leukemia. Pediatr Hematol Oncol 2002; 19: 543-51.
41. Sospedra M, Zhao Y, zur Hausen H, et al., Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 2005; 1: e41.
42. Maggi F, Andreoli E, Riente L, et al., Torquetenovirus in patients with arthritis. Rheumatology 2007; 46: 885-6.
43. Dark MJ., Whole-genome sequencing in bacteriology: state of the art. Infect Drug Resist 2013; 6: 115-23.
44. Lee TH, Kim WR, Poterucha JJ,. Evaluation of elevated liver enzymes. Clin Liver Dis 2012; 16: 183-98.
45. Schindhelm RK, Diamant M, Dekker JM, et al., Alanine aminotransferase as a marker of non-alcoholic fatty liver disease in relation to type 2 diabetes mellitus and cardiovascular disease. Diabetes Metab Res Rev 2006; 22: 437-43.
46. Matsushita Y, Takahashi Y, Mizoue T, et al.,; JPHC Study Grou p. Overweight and obesity trends among Japanese adults: a 10-year follow-up of the JPHC Study. Int J Obes 2008; 32: 1861-7.
47. Eguchi Y, Hyogo H, Ono M, et al., Prevalence and associated metabolic factors of nonalcoholic fatty liver disease in the general population from 2009 to 2010 in Japan: a multicenter large retrospective study. J Gastroenterol 2012; 47: 586-95.
48. Leclercq I, Horsmans Y, De Bruyere M, et al., Influence of body mass index, sex and age on serum alanine aminotransferase (ALT) level in healthy blood donors. Acta Gastroenterol Belg 1999; 62: 16-20.
49. Ayonrinde OT, Olynyk JK, Beilin LJ, et al., Gender-specific differences in adipose distribution and adipocytokines influence adolescent nonalcoholic fatty liver disease. Hepatology 2011; 53: 800-9.
50. Kleinman SH, Glynn SA, Lee TH, et al., Prevalence and quantitation of parvovirus B19 DNA levels in blood donors with a sensitive polymerase chain reaction screening assay. Transfusion 2007; 47: 1756-64.